Becton Dickinson (BDX): Rep. Robert P. Bresnahan Jr. (PA08) disclosed a purchase $1K–$15K
Rep. Robert P. Bresnahan Jr. (PA08) disclosed a purchase of Becton Dickinson in the $1K–$15K range.
- $1,001–$15,000
- Reported range · official band, not an exact amount
- 25 days
- Disclosure lag
- Traded
- May 15, 2025
- Disclosed
- Jun 9, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Mar 5, 2025CongressDisclosed sale of BDX — reported range $15,001 - $50,000
- Mar 18, 2025InsiderOfficer sold ~$106K of BDX shares in the open market
- Apr 8, 2025CongressDisclosed sale of BDX — reported range $1,001 - $15,000
- Apr 9, 2025InsiderOfficer sold ~$94K of BDX shares in the open market
- May 13, 2025CongressDisclosed purchase of BDX — reported range $1,001 - $15,000
- May 15, 2025 · this disclosureCongressDisclosed purchase of BDX — reported range $1,001 - $15,000
What came next
- Jun 2, 2025InsiderOfficer sold ~$200K of BDX shares in the open market
- Jun 17, 2025Congress · 1 personMembers of Congress: 2 purchases
- Jun 24, 2025CongressDisclosed sale of BDX — reported range $1,001 - $15,000
- Jul 8, 2025FDARecall: BD Trucount Controls, 30 Test - REF: 664343, RxOnly, IVD
- Jul 10, 2025FDAFDA device clearance: Marquee Disposable Core Biopsy Instrument and Instrument Kit
- Jul 10, 2025FDARecall: Description/REF: BD PYXIS MEDBANK MINI 1FH-1FM/169-137, BD PYXIS MEDBANK MINI 4HM/169-113, BD PYXIS MEDBANK MINI 4HH/169-112, BD PYXIS MEDBANK MINI 3HH-1HM/169…
- Jul 11, 2025FDAFDA device clearance: BD Cathena Safety IV Catheter
- Jul 17, 2025FDARecall: SureStep Foley Tray System Bardex I.C. Complete Care Infection Control Foley Catheter Tray, REF: A303316A
- Jul 17, 2025FDARecall: SureStep Foley Tray System Lubri-Sil I.C. Complete Care Infection Control Foley Catheter Tray, REF: A303414A
- Jul 17, 2025FDARecall: SureStep Foley Tray System BARD¿ Lubri-Sil Foley Catheter Tray, REF: A942216
- Jul 18, 2025Insider · 1 personInsiders: 2 sales (~$214K)
- Jul 24, 2025FDAFDA device clearance: Onflex Mesh
- Jul 25, 2025FDAFDA device clearance: BD Nexiva Closed IV Catheter System
- Jul 29, 2025FDAFDA device clearance: BD Plastipak Syringe
- Aug 8, 2025FDAFDA device clearance: BD Phoenix Automated Microbiology System - GN Eravacycline (0.125-2 µg/mL)
- Aug 8, 2025InsiderDirector sold ~$166K of BDX shares in the open market
- Aug 11, 2025InsiderDirector purchased ~$1.01M of BDX shares in the open market
- Aug 21, 2025FDARecall: Venclose digiRF Generators, Model VCRFG1, with software 3.35 designed to identify internal wiring anomalies in the Venclose EVSRF Ablation Catheter prior to us…
- Aug 22, 2025InsiderOfficer sold ~$11K of BDX shares in the open market
- Sep 5, 2025FDAFDA device clearance: Vaccess CT Low-Profile Power-Injectable Implantable Port; Vaccess CT Power-Injectable Implantable Port; PowerPort duo M.R.I. Implantable Port
How to read House Clerk periodic transaction report
The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.
Full guide: What is the STOCK Act?
What else is on file for Becton Dickinson
For Becton Dickinson, OQRO holds 8 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BDX page.
Other recent filings by Rep. Robert P. Bresnahan Jr. (PA08)
- House Clerk periodic transaction report at Berkshire Hathaway (BRK.B)Dec 19, 2025
- House Clerk periodic transaction report at Gitlab (GTLB)Jul 8, 2025
- House Clerk periodic transaction report at Amazon (AMZN)Jul 8, 2025
- House Clerk periodic transaction report at AppLovin (APP)Jul 8, 2025
- House Clerk periodic transaction report at Atlassian (TEAM)Jul 8, 2025
The full history of Rep. Robert P. Bresnahan Jr. (PA08) is on the profile page.
How this filing works
Explore the data
Common questions
Which member of Congress traded Becton Dickinson (BDX) stock, and how much?
Rep. Robert P. Bresnahan Jr. (PA08) disclosed a purchase of Becton Dickinson in the $1K–$15K range. Reported range, not an exact amount.
When did it happen, and when was it made public?
Traded: May 15, 2025. Disclosed: Jun 9, 2025. That is 25 days between the two dates.
Why is the amount a range and not an exact figure?
Members of Congress report each trade in a bracket set by law ($1,001 to $15,000, $15,001 to $50,000, and so on), never an exact amount. OQRO keeps the bracket as filed and does not estimate a figure inside it.
Where does this information come from?
From the House Clerk periodic transaction report, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Becton Dickinson recently?
For Becton Dickinson, OQRO holds 8 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the BDX page.
Does this mean BDX stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Becton Dickinson
- SEC Form 13F-HRNov 16, 2026
- SEC Form 144Nov 10, 2026
- SEC Form 4Nov 9, 2026
- SEC Form 144Nov 5, 2026
- SEC Form 4Oct 27, 2026
- SEC Form 144Oct 26, 2026
Everything OQRO holds on this company is on its BDX page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
